Investor Relations FAQ

    

Financial information
Shareholder services
Share information
Corporate governance and sustainability
General information

Financial information

Q. What were Novo Nordisk’s total sales in 2013?

A. Novo Nordisk’s total sales in 2013 were DKK 83.572 million

 

Q. What was Novo Nordisk’s net profit in 2013?

A. Novo Nordisk’s net profit in 2013 was DKK 25.184 million

 

Q. What was Novo Nordisk's free cash flow in 2013?

A. Novo Nordisk’s free cash flow was DKK 22.358 million in 2013

 

Q. How much did Novo Nordisk spend on Research and Development (R&D) in 2013?

A. Novo Nordisk spent DKK 11.733 million on R&D in 2013

 

Q. Where do I obtain key financial information?

A.  Click here for link to downloadable financial data

 

Q. How do I get copies of financial documents, e.g. the annual reports, quarterly reports or the form 20F?

A.Click here for Annual ReportsQuarterly Reports or Form 20F

 

Q. When are the next earnings release scheduled for?

A. Click here for link to the financial calendar

 

Q. When is the next Annual General Meeting?

A. Click here for link to the financial calendar

 

Q. When is Novo Nordisk’s fiscal year?

A. Novo Nordisk’s fiscal year is January 1 to December 31.

 

Shareholder services

Q. How or where can I buy Novo Nordisk A/S B-shares?

A. Novo Nordisk shares can be bought or sold through a stock broker, bank, or generally through a financial institution that provides brokerage services

 

Q. Where should I direct equerries concerning dividend payments, transfer of share certificates, consolidation of shareholder accounts and tracing of lost shares?

A.
Outside North America:
Danske Bank
Holmens Kanal 2-12
1092 Copenhagen K
Denmark
Phone +45 3344 0000

In North America:
JPMorgan Chase & Co.
PO Box 64504
St Paul, Mn 55164-0504
USA
Phone: +1 800 990 1135
Phone: +1 651 453 2128 for enquiries from outside the United States
E-mail: jpmorgan.adr@wellsfargo.com

Share information

Q. Where can I find historical stock prices?

A. Click here for link to stock charts

 

Q. Where can I find information about Novo Nordisk’s stock split history, share capital history and historical dividend payments?

A. Click here for link to dividend and capital history

 

Q. What is the number of outstanding shares?

A. Click here for link to facts about the share

 

Q. What is the difference between Novo Nordisk A- and B-shares?

A. Click here for link to facts about the share

 

Q. On what stock exchanges are Novo Nordisk traded and what are the stock symbols?

A. Click here for link to facts about the share

 

Q. What are ADRs/ADSs?

A. ADR is an abbreviation for an American Depository Receipt. ADS is an abbreviation for an American Depository Share. An ADR is a receipt for the shares of a foreign-based corporation held in the vault of a U.S. bank, entitling the shareholder to all dividends and capital gains. An ADR is the certificate that represents a number of ADSs.

 

Q. What is Novo Nordisk cusip number for its ADRs/ADSs traded on the New York Stock Exchange?

A. The CUSIP number is 670100205

 

Q. Does Novo Nordisk have a share repurchase programme?

A. Yes, Novo Nordisk has decided to implement a new share repurchase programme with an expected total repurchase value of B shares amounting to a cash value of up to DKK 15 billion for 1 February 2014 to 31 January 2015.

 

Q. Where do I find information on apportionment of the tax basis in Novo Nordisk A/S shares held prior to the demerger between shares held in Novo Nordisk A/S and shares received in Novozymes A/S in connection with the demerger?

A. Click here for link to the Apportionment Document

 

Corporate governance and sustainability

Q. How do I find out more about Novo Nordisk and Corporate Governance?

A. Click here for link to Novo Nordisk’s Corporate Governance section

 

Q. Are there any differences between Novo Nordisk stand on Corporate Governance and the New York Stock Exchange guidelines?

A. Click here for link to the Corporate Governance codes

 

Q. How do I find out more about Novo Nordisk and Corporate Sustainability?

A. Click here for link to Novo Nordisk’s Corporate Sustainability section

 

Q. Where can I find information about Novo Nordisk’s Articles of Association?

A. Read Novo Nordisk’s Articles of Association in English and in Danish.

 

General information

Q. What is Novo Nordisk’s mission statement?

A. Click here for link to the Novo Nordisk way 

Q. Where do I find information on Novo Nordisk’s rules of conduct?

A. Click here for link to the Novo Nordisk way
 

Q. What are Novo Nordisk’s long-term financial targets?

A. Novo Nordisk’s long-term financial targets are:

  • Operating profit growth (EBIT) of 15% per annum
  • Operating margin (EBIT margin) of 40% per annum
  • Operating profit after tax to net operating assets of 125% per annum
  • Cash to earnings ratio of 90% as a three-year average

 

Q. Where can I obtain information on Novo Nordisk’s pipeline?

A. Click here for link to the pipeline

 

Q. Which accounting convention does Novo Nordisk adhere to?

A. As of 1 January 2004, the accounting policies have been changed to comply with International Financial Reporting Standards (IFRS). The date of transition is 1 January 2002 and all comparative figures for 2000-2003 have been restated. Following IFRS 1 all standards and interpretations effective at 31 December 2004 have been applied. Note 39 in the Annual Report 2004 makes a reconciliation to US GAAP.

 

Q. Who are Novo Nordisk’s auditor?

A. PWC 

Q. Who is Novo Nordisk’s Executive Management?

A. Click here for link to the Executive Management

 

Q. Who are the Investor Relations staff members?

A. Click here for link to Investor Relations